KJ015
/ Shanghai Bao Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 27, 2025
A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
(clinicaltrials.gov)
- P1 | N=66 | Not yet recruiting | Sponsor: Shanghai Bao Pharmaceuticals Co., Ltd.
New P1 trial • Biliary Cancer • Breast Cancer • Cholangiocarcinoma • Colorectal Cancer • Esophageal Cancer • Gastric Cancer • Head and Neck Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck
1 to 1
Of
1
Go to page
1